Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Emerging roles of F-box proteins in cancer drug resistance
Linzhi Yan, Min Lin, Shuya Pan, et al.
Drug Resistance Updates (2019) Vol. 49, pp. 100673-100673
Open Access | Times Cited: 66

Showing 1-25 of 66 citing articles:

Anticancer drug resistance: An update and perspective
Ruth Nussinov, Chung‐Jung Tsai, Hyunbum Jang
Drug Resistance Updates (2021) Vol. 59, pp. 100796-100796
Open Access | Times Cited: 248
Novel nanomedicines to overcome cancer multidrug resistance
Zhenwei Su, Shaowei Dong, Shan‐Chao Zhao, et al.
Drug Resistance Updates (2021) Vol. 58, pp. 100777-100777
Closed Access | Times Cited: 137
Clinical significance of FBXW7 loss of function in human cancers
Jingyi Fan, Marcia Bellon, Mingyi Ju, et al.
Molecular Cancer (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 86
Emerging roles of long noncoding RNAs in chemoresistance of pancreatic cancer
Wangkai Xie, Man Chu, Gendi Song, et al.
Seminars in Cancer Biology (2020) Vol. 83, pp. 303-318
Closed Access | Times Cited: 96
Multifunctional nanolocks with GSH as the key for synergistic ferroptosis and anti-chemotherapeutic resistance
Jiawei Zhu, Xiaorui Wang, Yan Su, et al.
Biomaterials (2022) Vol. 288, pp. 121704-121704
Closed Access | Times Cited: 60
Remodeling endogenous H2S microenvironment in colon cancer to enhance chemodynamic therapy
Donglin Liu, Mengjun Liu, Ying Wan, et al.
Chemical Engineering Journal (2021) Vol. 422, pp. 130098-130098
Closed Access | Times Cited: 57
FOXO3a in cancer drug resistance
Ying Liu, Yu Wang, Xiaoge Li, et al.
Cancer Letters (2022) Vol. 540, pp. 215724-215724
Closed Access | Times Cited: 54
Targeting matrix metalloproteinases by E3 ubiquitin ligases as a way to regulate the tumor microenvironment for cancer therapy
Jinxin Liu, Ting Chen, Shizhe Li, et al.
Seminars in Cancer Biology (2022) Vol. 86, pp. 259-268
Closed Access | Times Cited: 44
Nanomedicine Combats Drug Resistance in Lung Cancer
Xiuli Zheng, Xiao-Hai Song, Guonian Zhu, et al.
Advanced Materials (2023) Vol. 36, Iss. 3
Closed Access | Times Cited: 35
The E3 ubiquitin ligases regulate PD-1/PD-L1 protein levels in tumor microenvironment to improve immunotherapy
Bo Hou, Ting Chen, He Zhang, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 26
The roles of m6A methylation in cervical cancer: functions, molecular mechanisms, and clinical applications
Zhonghao Mao, Bingyu Wang, Teng Zhang, et al.
Cell Death and Disease (2023) Vol. 14, Iss. 11
Open Access | Times Cited: 22
Lenvatinib in hepatocellular carcinoma: Resistance mechanisms and strategies for improved efficacy
Y. Qin, Shisong Han, Yahan Yu, et al.
Liver International (2024) Vol. 44, Iss. 8, pp. 1808-1831
Closed Access | Times Cited: 11
Recent advances of podophyllotoxin/epipodophyllotoxin hybrids in anticancer activity, mode of action, and structure-activity relationship: An update (2010–2020)
Jiaqi Xiao, Meixiang Gao, Zhou Sun, et al.
European Journal of Medicinal Chemistry (2020) Vol. 208, pp. 112830-112830
Closed Access | Times Cited: 60
Fbxo45 facilitates pancreatic carcinoma progression by targeting USP49 for ubiquitination and degradation
Linhui Wu, Ke Yu, Kai Chen, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 3
Open Access | Times Cited: 36
Notch signaling pathway: a comprehensive prognostic and gene expression profile analysis in breast cancer
Hassan Yousefi, Afshin Bahramy, Narges Zafari, et al.
BMC Cancer (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 33
Targeting CSC-related transcription factors by E3 ubiquitin ligases for cancer therapy
Weijia Wang, Wenjun Liu, Qiuli Chen, et al.
Seminars in Cancer Biology (2022) Vol. 87, pp. 84-97
Closed Access | Times Cited: 28
FBXW7 in breast cancer: mechanism of action and therapeutic potential
Siyu Chen, Ping Leng, Jinlin Guo, et al.
Journal of Experimental & Clinical Cancer Research (2023) Vol. 42, Iss. 1
Open Access | Times Cited: 16
The characteristics and roles of β‐TrCP1/2 in carcinogenesis
Yanli Bi, Danrui Cui, Xiufang Xiong, et al.
FEBS Journal (2020) Vol. 288, Iss. 11, pp. 3351-3374
Open Access | Times Cited: 49
The E3 ubiquitin ligases regulate inflammation in cardiovascular diseases
Xiaohong Chen, Jia Ma, Zhiwei Wang, et al.
Seminars in Cell and Developmental Biology (2023) Vol. 154, pp. 167-174
Closed Access | Times Cited: 14
Role and regulation of FOXO3a: new insights into breast cancer therapy
Wenqiu Mei, Bingyin Mei, Jing Chang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 5
Emerging role of FBXO22 in carcinogenesis
Jiangting Cheng, Min Lin, Man Chu, et al.
Cell Death Discovery (2020) Vol. 6, Iss. 1
Open Access | Times Cited: 37
Activation of the integrated stress response is a vulnerability for multidrug‐resistant FBXW7 ‐deficient cells
Laura Sanchez‐Burgos, Belén Navarro‐González, Santiago García‐Martín, et al.
EMBO Molecular Medicine (2022) Vol. 14, Iss. 9
Open Access | Times Cited: 19
Targeting immune cell types of tumor microenvironment to overcome resistance to PD-1/PD-L1 blockade in lung cancer
Man Wang, Lijie Zhu, Xiaoxu Yang, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 12
FBXO45 is a potential therapeutic target for cancer therapy
Min Lin, Zhiwei Wang, Xueqiong Zhu
Cell Death Discovery (2020) Vol. 6, Iss. 1
Open Access | Times Cited: 32
Hydroxamic acid hybrids as the potential anticancer agents: An Overview
Wenhua Liu, Yuchen Liang, Xiaoyong Si
European Journal of Medicinal Chemistry (2020) Vol. 205, pp. 112679-112679
Closed Access | Times Cited: 31
Page 1 - Next Page

Scroll to top